Zobrazeno 1 - 10
of 14
pro vyhledávání: '"William S. May"'
Autor:
Trung C. Nguyen, Anne Liu, Li Liu, Chalmette Ball, Hiuwan Choi, William S. May, Khatira Aboulfatova, Angela L. Bergeron, Jing-fei Dong
Publikováno v:
Haematologica, Vol 92, Iss 1 (2007)
We studied the state of ultralarge von Willebrand factor (ULVWF) proteolysis in 21 pediatric patients with severe sepsis and found that the overall group of patients had moderately reduced ADAMTS-13 activity, but 31% had severe enzymatic deficiency.
Externí odkaz:
https://doaj.org/article/43b60f2ba4ed4a33b582312fe9d692da
Publikováno v:
Hematology/Oncology and Stem Cell Therapy, Vol 14, Iss 3, Pp 246-251 (2021)
Despite improvements in first‐line treatment of T‐cell acute lymphoblastic leukemia (T‐ALL), the outcome of relapsed T-ALL remains dismal with less than 7% achieving a long-term survival. Thus, there is an unmet need for new treatment strategie
Autor:
Kimberly E. Hawkins, John R. Wingard, Elizabeth Wise, Christopher R. Cogle, John W. Hiemenz, Leslie Pettiford, Daniel Turner, Christina Cline, William S. May, Raphael C. Bosse, Bradley Collins, Jan S. Moreb, Randall Brown, Zackary Beachamp, Fatih M. Uckun, Maxim Norkin, Jack W. Hsu
Publikováno v:
British Journal of Haematology. 189
Autor:
John R. Wingard, Jack W. Hsu, Nosha Farhadfar, Debra Lynch Kelly, Randy A. Brown, Hemant S. Murthy, Wendy J. Dahl, Lacey Mead, James Colee, Shalini Nair, John W. Hiemenz, Vivian Irizarry Gatell, William S. May
Publikováno v:
Biol Blood Marrow Transplant
BACKGROUND: Hematopoietic stem cell transplant (HCT) survivors are burdened by a high prevalence and early onset of chronic disease. Healthy dietary patterns have been associated with lower risks of chronic health conditions in the general population
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cbbf7312881ee5687031c9e493f0b64
https://europepmc.org/articles/PMC7271096/
https://europepmc.org/articles/PMC7271096/
Autor:
John W. Hiemenz, Nosha Farhadfar, William Paul Skelton, Jonathan Lambird, William S. May, Hemant S. Murthy, John R. Wingard, Jack W. Hsu, Christopher R. Cogle, Randy A. Brown, Yu Wang
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S301-S302
Introduction Absolute lymphocyte count (ALC) recovery following autologous stem cell transplant(ASCT) has been shown to be an important factor for overall and progression free survival. This is thought to be mediated by improved immune reconstitution
Autor:
John W. Hiemenz, Christopher R. Cogle, John R. Wingard, Sican Xiong, Jan S. Moreb, William S. May, Jack W. Hsu, Randall Brown, Maxim Norkin, Fei Zou, Ilicia L. Shugarman, Michael Byrne
Publikováno v:
Journal of clinical apheresis. 33(1)
Background Peripheral blood stem cell (PBSC) mobilization is routinely undertaken prior to autologous stem cell transplantation (ASCT) in patients with multiple myeloma (MM). A number of studies have identified risk factors for poor PBSC mobilization
Publikováno v:
Case Reports in Hematology
Case Reports in Hematology, Vol 2017 (2017)
Case Reports in Hematology, Vol 2017 (2017)
Chronic myeloid leukemia (CML) and mantle cell lymphoma (MCL) are hematologic malignancies that originate from different oligopotent progenitor stem cells, namely, common myeloid and lymphoid progenitor cells, respectively. Although blastic transform
Autor:
Myron Chang, Randall Brown, William S. May, Jack W. Hsu, Jan S. Moreb, John R. Wingard, John W. Hiemenz, Maxim Norkin
Publikováno v:
Biology of Blood and Marrow Transplantation. 22(3)
Publikováno v:
Gene. 444:1-9
Tnk1/Kos1 is a non-receptor protein tyrosine kinase found to be a tumor suppressor. It negatively regulates cell growth by indirectly suppressing Ras activity. We identified and characterized the critical cis-elements required for Tnk1/Kos1's promote
Autor:
Takahiko Nakagawa, William S. May, Puneet Sood, Michiko Shimada, Bhagwan Dass, Quoc C. Van, Richard J. Johnson, Vijaykumar Lingegowda, A. Ahsan Ejaz
Publikováno v:
Nephrology Dialysis Transplantation. 24:2960-2964
Tumour lysis syndrome (TLS) is a complication associated with the treatment of tumour types with high proliferative rate, large tumour burden or high sensitivity to cytotoxic therapy. The implementation of risk stratification strategies [1], appropri